James Brian Windsor, President and CEO at Aileron Therapeutics, Inc. (ALRN), bought 400 shares at $2.24 ($898) on 2024-12-05, disclosed to the SEC on 2024-12-09.
Open-market purchase of $898 ALRN by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.24 | 239 | $535 | 59.6% |
| 2 | $2.25 | 161 | $362 | 40.4% |
| Total | $2.24 avg | 400 | $898 | 100% |
| Filing → |
| ALRN | BUY | 2023-11-21 | $10K | — | Filing → |
| TFFP | SELL | 2020-12-09 | $395K | — | Filing → |
| TFFP | BUY | 2019-10-29 | $25K | — | Filing → |